Sign In
National
Novo Nordisk Targets ₹8,600 Crore India Sales with Weight-Loss Drug Wegovy
Pharma
Dr. Reddy’s tells Delhi HC it will not sell Novo Nordisk's Ozempic-like drug in India
Life Style
Eli Lilly’s Drug Likely To Dominate Global Obesity Market: Report
Novo Nordisk's obesity drug can reduce heart problem risk by 20%: Study
